At-home vaginal tests compared
An honest comparison of pH test strips, mail-in swab kits, microbiome sequencing and wearable sensors: what each one measures, costs and cannot tell you.
At-home vaginal testing has gone from pharmacy pH strips to mail-in genomic sequencing in about a decade. The options measure genuinely different things, at very different prices, with very different evidence behind them. We make one of these products, so read the comparison with that in mind. We have tried to be straight about where we sit.
The options at a glance
| Type | Measures | Result in | Typical cost |
|---|---|---|---|
| pH test strips | Vaginal pH only | Seconds | $10–20 for a pack |
| Mail-in swab (PCR) | A fixed panel of named organisms | Days to weeks | $100–200 |
| Mail-in sequencing (mNGS) | The whole microbial community | 1–3 weeks | $130–250 |
| Biosensor wearable | Chemical change over a wear period | Same day | Not yet on sale |
pH test strips
What they do: a strip touched to the vaginal wall changes color, read against a chart. Brands include AZO and a wide range of generic options.
Genuinely useful for: the BV-versus-yeast question. Elevated pH with a fishy odor points toward BV; normal pH with itching points toward yeast. That single distinction is the main reason to own them, and at this price it is reasonable value.
Where they fall down: pH is raised by menstruation, semen within 12 hours, douching and menopause, so the same reading has many explanations. See vaginal pH. Reading a color against a chart is subjective, and the reference range printed on most packs assumes a reproductive-age user, making them misleading after menopause.
Mail-in PCR swab panels
What they do: you swab, mail it, a lab runs PCR against a fixed list of targets: commonly BV-associated organisms, Candida species, and often STIs including chlamydia, gonorrhea and trichomoniasis.
Strong for: STI screening at home, and identifying specific named organisms with good accuracy. Many services include clinician review and, where regulations allow, a prescription.
Limitations: PCR only finds what it looks for. Anything off the panel is invisible, and a "negative" result means "none of the listed targets", not "nothing there". Turnaround is days to weeks, which is a long time with active symptoms.
Daye uses a different collection method, a diagnostic tampon rather than a swab, sampling more broadly across the vaginal canal, with PCR analysis. It is UK-based, and has published performance figures for its collection method.
Metagenomic sequencing
What it does: sequences the genetic material in the sample and identifies essentially everything present, with relative abundances: hundreds of organisms rather than a fixed panel.
Evvy is the best-known provider. Its methodology has been independently validated and published in the peer-reviewed literature, reporting sensitivity around 93% and specificity around 90%. That published validation is a real advantage and it is worth saying so plainly.
Strong for: unexplained recurrent symptoms where standard testing has not produced an answer, understanding your community state type, and identifying organisms a fixed panel would miss.
Limitations: cost, and turnaround of one to three weeks. More significantly, more data is not automatically more useful. Detecting an organism does not establish it is causing your symptoms, and a diverse microbiome is normal and asymptomatic for a substantial proportion of people, with a consistent skew by ethnicity in the reference cohorts. See what a healthy microbiome looks like. There is a genuine risk of treating a report rather than a person.
Biosensor wearables
What they do: sensing material integrated into a worn product responds to chemical change during ordinary wear. Vagilant sits here: nine colorimetric pads on a liner, read by you and entered into an assessment.
The argument for the category: no separate testing event, results the same day, no lab, and, because it is a liner you wear anyway, low enough friction to repeat, which makes trend data realistic rather than theoretical. Repeated measurement is the thing every other option is bad at.
The honest limitations: this is the newest and least-validated category. In our case specifically, we have internal testing with volunteer users and no independent peer-reviewed validation, so we cannot quote accuracy figures the way Evvy can. It also cannot identify a specific organism, since chemical change is not species identification, and it cannot screen for STIs at all. Our full position is on the science page.
Which to choose
| If you want to… | Consider |
|---|---|
| Tell BV and yeast apart, cheaply, today | pH strips |
| Screen for STIs at home | Mail-in PCR panel |
| Investigate recurrent symptoms nothing has explained | Sequencing, ideally alongside a clinician |
| Track change over weeks and months | A wearable sensor, or a written log |
| Get a diagnosis | See a clinician. None of the above diagnoses anything. |
What none of them do
No at-home vaginal test diagnoses you.
Ours included. Diagnosis requires clinical assessment: history, examination, and usually microscopy or culture. At-home testing produces information to bring to that process. Used well it makes appointments more productive; used instead of an appointment it delays care.
Be particularly cautious about: results that arrive weeks after symptoms started; services that sell treatment on the back of their own test result; anything promising to "rebalance" or "optimize" an asymptomatic microbiome; and marketing that treats a detected organism as a diagnosis.
The cheapest useful option
Worth stating even though it competes with everything above, including us: a written record costs nothing. Note the date, what you observed, where you are in your cycle, and what you tried. For most people with intermittent symptoms, that record delivers more clinical value than any single test result, because it captures the pattern, which is what a clinician actually needs. See talking to your doctor.
Sources
- Centers for Disease Control and Prevention, STI Treatment Guidelines.
- American College of Obstetricians and Gynecologists, Vaginitis in Nonpregnant Patients.
- Evvy, published validation of metagenomic sequencing methodology, Diagnostics.
- Ravel J, et al. Vaginal microbiome of reproductive-age women. PNAS.
This article is for general information and is not medical advice. Vagilant is a wellness product for health monitoring and education. It is not a diagnostic medical device and does not diagnose infections or conditions. If you have symptoms or concerns, speak to a doctor or other qualified healthcare provider.